If Holly Springs is landing billions in biotech investment, why did its home builders pull fewer permits last year than they have in a decade?
Start with what happened in Holly Springs in August 2026. Wake County's Register of Deeds recorded just 26 residential closings in town that month, and those 26 sales carried a median price of $744,000, the highest of any town in South Wake, higher than Apex's 141 sales at a median of $631,500 and well above Fuquay-Varina's 92 sales at $447,500. The single highest closing in Holly Springs that month was a newly built home on Weston Farm Way that sold for $2.04 million.
Pull a different tracker for the same town in the same general window and the number looks nothing like $744,000. MLS-sourced figures updated in early September 2026 put Holly Springs' six-month median closing price at $582,749, with the middle half of sales landing between $440,000 and $772,000. A separate August 2026 update pegged the month's median sold price at $581,250, up just 1.1 percent year over year.
None of these numbers are wrong. They are measuring different things, and the gap between them is the actual story worth understanding if you're comparing Holly Springs against Cary, Apex, or Wake Forest right now.
Same Town, Same Month, Two Different Medians
The county deed data captures every closing that got recorded, full stop, whether it's a starter resale or a $2 million new build. With only 26 sales in a month, one or two high-end new-construction closings can swing the median by six figures. That's exactly what happened on Weston Farm Way. The MLS-based trackers use a rolling window and a larger sample, so a single luxury closing gets diluted rather than dominating the number.
Neither number tells you what your specific house, in your specific neighborhood, is worth. A three-bedroom resale in Holly Glen and a new build going up near Norris Crossing at a $677,000 to $839,000 price band are competing in almost entirely different markets, even though both show up in the same "Holly Springs median" headline. New construction landing at a specific price point doesn't tell you what a 2005-built home two miles away is worth. It tells you what a different product, aimed at a different buyer, closed for that month.
This matters more in Holly Springs than in a lot of comparable towns because the town is still building out in a way that older, land-constrained neighbors like Chapel Hill simply can't. Southern and western Holly Springs still have developable land, which means the new-construction share of any given month's closings can be large enough to move the citywide number around without a single existing homeowner gaining or losing value.
The Biotech Money Everyone Has Heard About
The reason Holly Springs gets described as a hot market in the first place is real. Since 2022, three of the world's largest biotech and pharmaceutical companies have committed billions of dollars to manufacturing campuses in town.
| Company | Investment | New Jobs | Average Wage | Timeline |
|---|---|---|---|---|
| Amgen | More than $1.5 billion total across two phases | 725 jobs by 2032 | $91,527 | First facility targeted for 2026; hiring ramps through 2032 |
| Fujifilm Diosynth Biotechnologies | $3.2 billion across two announcements | Over 1,400 jobs | $109,923 | Expanding into one of North America's largest cell-culture manufacturing sites |
| Genentech | About $2 billion | More than 500 jobs | Not disclosed | Operational by the end of 2029 |
Those wages matter for the housing conversation specifically because they sit well above Wake County's average annual wage, which state commerce officials put around $75,000. A workforce earning six figures on average, arriving over the next several years, is exactly the kind of demand that should show up in home prices eventually.
CSL Seqirus has been in Holly Springs since 2006 and has expanded its vaccine manufacturing site multiple times since, including a $156 million addition in 2022 that brought the facility to roughly 475,000 square feet. The point isn't that this is a sudden 2026 event. Holly Springs has been building a life sciences identity for two decades. What's new is the scale and the compressed timeline of the last three years.
The Permit Number That Doesn't Fit the Story
Here's the part that doesn't line up with a straightforward "biotech jobs push housing demand" narrative. The town's own FY27 budget message reports that 2025 single-family and townhome permits fell to under 300, down from a 10-year average of 600, even as roughly 5,200 approved-but-unbuilt residential units remain sitting in the pipeline. Total real estate value in town has still grown by more than 7 percent annually, but the number of new homes builders are actually pulling permits to start has been cut in half.
That's not a story about the town blocking growth. Those 5,200 units already cleared approval. It's a story about builders choosing not to break ground on projects they're already entitled to build, almost certainly because higher interest rates and construction financing costs make holding land more attractive than building spec homes into a market where days on market have stretched out. Local MLS data for August 2026 shows active inventory in Holly Springs up 12.6 percent year over year while closed sales fell 12.7 percent over the same period, with median days on market climbing to 20.
Put those two facts side by side. Thousands of high-wage biotech jobs are scheduled to hit the local labor market between now and 2032, most heavily as Genentech's plant comes online in 2029 and Amgen's second facility ramps toward its 2032 headcount target. At the same time, the pipeline of new homes that would house those workers has slowed to its lowest permit volume in a decade. The demand curve and the supply curve are not moving on the same clock, and right now supply is the one that paused.
What This Means If You're Comparing Neighborhoods
If you're weighing Holly Springs against Apex or Cary based on a single median number, you're comparing apples that were harvested at completely different times. The more useful comparison is price per square foot and days on market inside a specific pocket over a 60 to 90 day window, not a townwide figure built from whatever 26 or 56 homes happened to close that month.
Established neighborhoods like 12 Oaks and Sunset Ridge are competing against newer construction near Ting Park and along the Holly Springs Towne Center corridor, and those two products draw different buyers even when they show up in the same headline median. An older home in Holly Glen or Woodcreek carries a different value proposition than a 2026-built home at Norris Crossing, and no citywide number captures that difference.
The permit slowdown also cuts against the assumption that waiting a year or two guarantees more competitively priced new construction. Builders are sitting on approved land rather than releasing new inventory at pace, which means the current window, with inventory up and days on market stretching, may be a better moment to negotiate on an existing new-construction listing than a future window where the already-approved pipeline gets released all at once to meet a hiring wave that's still two to six years out.
FAQ
Is Holly Springs currently a buyer's market or a seller's market? Neither cleanly. Inventory rose 12.6 percent year over year as of August 2026 and days on market lengthened to 20, which gives buyers more room to negotiate than they had a year ago. But well-priced, updated homes are still moving quickly, which keeps it from tipping fully into buyer's-market territory.
Why did new home permits fall if biotech investment keeps growing? The two are on different timelines. Most of the announced biotech hiring, particularly Genentech's and the later phase of Amgen's expansion, doesn't fully land until 2029 through 2032. Builders appear to be responding to current financing costs and absorption speed rather than to hiring that's still years out.
Does a high median price in one month mean Holly Springs values are rising fast? Not on its own. A month with only 26 recorded closings, like August 2026, can be swung by a single high-end new-construction sale. The more reliable read is a rolling multi-month median paired with price per square foot in the specific neighborhood you're comparing.
The biotech jobs are real, the money behind them is real, and the town's own housing pipeline has not yet caught up to either one. That gap is where the actual opportunity sits for anyone deciding whether to buy now or wait.
If you want a read on how a specific Holly Springs neighborhood is actually pricing right now instead of a townwide average, The Oxford Team can pull the comps for your pocket of town and walk you through what they mean.